BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 29054368)

  • 1. An intermediate level of CD161 expression defines a novel activated, inflammatory, and pathogenic subset of CD8
    Nicol B; Salou M; Vogel I; Garcia A; Dugast E; Morille J; Kilens S; Charpentier E; Donnart A; Nedellec S; Jacq-Foucher M; Le Frère F; Wiertlewski S; Bourreille A; Brouard S; Michel L; David L; Gourraud PA; Degauque N; Nicot AB; Berthelot L; Laplaud DA
    J Autoimmun; 2018 Mar; 88():61-74. PubMed ID: 29054368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of CD161 expression on human CD8+ T cells defines a distinct functional subset with tissue-homing properties.
    Billerbeck E; Kang YH; Walker L; Lockstone H; Grafmueller S; Fleming V; Flint J; Willberg CB; Bengsch B; Seigel B; Ramamurthy N; Zitzmann N; Barnes EJ; Thevanayagam J; Bhagwanani A; Leslie A; Oo YH; Kollnberger S; Bowness P; Drognitz O; Adams DH; Blum HE; Thimme R; Klenerman P
    Proc Natl Acad Sci U S A; 2010 Feb; 107(7):3006-11. PubMed ID: 20133607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of CD161 (NKR-P1A) defines subsets of human CD4 and CD8 T cells with different functional activities.
    Takahashi T; Dejbakhsh-Jones S; Strober S
    J Immunol; 2006 Jan; 176(1):211-6. PubMed ID: 16365412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD161(high)CD8+T cells bear pathogenetic potential in multiple sclerosis.
    Annibali V; Ristori G; Angelini DF; Serafini B; Mechelli R; Cannoni S; Romano S; Paolillo A; Abderrahim H; Diamantini A; Borsellino G; Aloisi F; Battistini L; Salvetti M
    Brain; 2011 Feb; 134(Pt 2):542-54. PubMed ID: 21216829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depletion of pro-inflammatory CD161(+) double negative (CD3(+)CD4(-)CD8(-)) T cells in AIDS patients is ameliorated by expansion of the γδ T cell population.
    Singleterry WL; Henderson H; Cruse JM
    Exp Mol Pathol; 2012 Feb; 92(1):155-9. PubMed ID: 22100877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-E restricted CD8+ T cell subsets are phenotypically altered in multiple sclerosis patients.
    Pannemans K; Broux B; Goris A; Dubois B; Broekmans T; Van Wijmeersch B; Geraghty D; Stinissen P; Hellings N
    Mult Scler; 2014 Jun; 20(7):790-801. PubMed ID: 24144875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smoking reduces circulating CD26
    Ammitzbøll C; Börnsen L; Romme Christensen J; Ratzer R; Romme Nielsen B; Søndergaard HB; von Essen MR; Sellebjerg F
    J Leukoc Biol; 2017 May; 101(5):1211-1220. PubMed ID: 28179539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of Circulating CD8+ CD161
    Acquaviva M; Bassani C; Sarno N; Dalla Costa G; Romeo M; Sangalli F; Colombo B; Moiola L; Martinelli V; Comi G; Farina C
    Front Immunol; 2019; 10():1922. PubMed ID: 31474991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral blood non-MAIT CD8+CD161hi cells are decreased in relapsing-remitting multiple sclerosis patients treated with interferon beta.
    Negrotto L; Cantó E; Río J; Tintoré M; Montalban X; Comabella M
    J Neuroimmunol; 2015 Nov; 288():98-101. PubMed ID: 26531701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low levels of peripheral CD161++CD8+ mucosal associated invariant T (MAIT) cells are found in HIV and HIV/TB co-infection.
    Wong EB; Akilimali NA; Govender P; Sullivan ZA; Cosgrove C; Pillay M; Lewinsohn DM; Bishai WR; Walker BD; Ndung'u T; Klenerman P; Kasprowicz VO
    PLoS One; 2013; 8(12):e83474. PubMed ID: 24391773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased CD161+CD8+ T cells in the peripheral blood of patients suffering from rheumatic diseases.
    Mitsuo A; Morimoto S; Nakiri Y; Suzuki J; Kaneko H; Tokano Y; Tsuda H; Takasaki Y; Hashimoto H
    Rheumatology (Oxford); 2006 Dec; 45(12):1477-84. PubMed ID: 16638798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Higher frequencies of CD161+ circulating T lymphocytes in allergic rhinitis patients compared to healthy donors.
    Poggi A; Canevali P; Contatore M; Ciprandi G
    Int Arch Allergy Immunol; 2012; 158(2):151-6. PubMed ID: 22286340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD161 Is Expressed in a Subset of T-Cell Prolymphocytic Leukemia Cases and Is Useful for Disease Follow-up.
    Gilles SR; Yohe SL; Linden MA; Dolan M; Hirsch B; Grzywacz B
    Am J Clin Pathol; 2019 Sep; 152(4):471-478. PubMed ID: 31305900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced Th1/Th17 Functions of CD161+ CD8+ T Cells in Mucosal Tissues of Rhesus Macaques.
    Rout N
    PLoS One; 2016; 11(6):e0157407. PubMed ID: 27309719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age and CD161 expression contribute to inter-individual variation in interleukin-23 response in CD8+ memory human T cells.
    Shen H; Zhang W; Abraham C; Cho JH
    PLoS One; 2013; 8(3):e57746. PubMed ID: 23469228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Aging on the Frequency, Phenotype, and Function of CD161-Expressing T Cells.
    van der Geest KSM; Kroesen BJ; Horst G; Abdulahad WH; Brouwer E; Boots AMH
    Front Immunol; 2018; 9():752. PubMed ID: 29725326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD8⁺ MAIT cells infiltrate into the CNS and alterations in their blood frequencies correlate with IL-18 serum levels in multiple sclerosis.
    Willing A; Leach OA; Ufer F; Attfield KE; Steinbach K; Kursawe N; Piedavent M; Friese MA
    Eur J Immunol; 2014 Oct; 44(10):3119-28. PubMed ID: 25043505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Innate signals overcome acquired TCR signaling pathway regulation and govern the fate of human CD161(hi) CD8α⁺ semi-invariant T cells.
    Turtle CJ; Delrow J; Joslyn RC; Swanson HM; Basom R; Tabellini L; Delaney C; Heimfeld S; Hansen JA; Riddell SR
    Blood; 2011 Sep; 118(10):2752-62. PubMed ID: 21791427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD161++ CD8+ T cells, including the MAIT cell subset, are specifically activated by IL-12+IL-18 in a TCR-independent manner.
    Ussher JE; Bilton M; Attwod E; Shadwell J; Richardson R; de Lara C; Mettke E; Kurioka A; Hansen TH; Klenerman P; Willberg CB
    Eur J Immunol; 2014 Jan; 44(1):195-203. PubMed ID: 24019201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Clinical Relevance of IL-17-Producing CD4+CD161+ Cell and Its Subpopulations in Primary Sjögren's Syndrome.
    Li L; He J; Zhu L; Yang Y; Jin Y; Jia R; Liu X; Liu Y; Sun X; Li Z
    J Immunol Res; 2015; 2015():307453. PubMed ID: 26436101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.